Benefits
Accidental Gluten Exposure Support
GluteAX designed for SUPPORT WITH ACCIDENTAL GLUTEN EXPOSURE — not for routine consumption of gluten by celiac patients (which remains contraindicated).
Non-Celiac Gluten Sensitivity Adjunct
May help those with non-celiac gluten sensitivity managing occasional gluten exposure.
Specific Gluten-Targeting Activity
Distinguished from generic protease blends — enzyme specifically active against gluten proteins (gliadin, glutenin).
BIO-CAT Quality
Industry-leading enzyme manufacturer with clinical research backing.
Travel/Dining Out Safety Net
Practical applications for travel and dining where gluten exposure may be unintended.
Mechanism of action
Gluten Protein Hydrolysis
Specific protease activity against gluten proteins (gliadin, glutenin) — breaks them down to smaller peptides less likely to trigger immune response.
Gastric pH Activity
Active in stomach acid environment where most gluten exposure occurs initially.
DPP-IV Activity
Some gluten enzymes have dipeptidyl peptidase-IV activity targeting proline-rich gluten peptides specifically.
Clinical trials
BIO-CAT clinical evaluation of GluteAX for gluten exposure applications.
Non-celiac gluten-sensitive adults.
Gluten exposure support; symptom reduction with accidental exposure.
About this ingredient
GLUTEAX® is a SPECIFIC GLUTEN-TARGETING ENZYME developed by BIO-CAT. GLUTEN BACKGROUND: protein complex (gliadin + glutenin) found in wheat, barley, rye; triggers autoimmune response in CELIAC DISEASE (~1% of population) and inflammatory response in NON-CELIAC GLUTEN SENSITIVITY (broader population); both conditions require gluten avoidance.
KEY DISTINCTIONS: (1) SPECIFIC GLUTEN-TARGETING activity vs broad-spectrum proteases; (2) Designed for ACCIDENTAL EXPOSURE management; (3) BIO-CAT clinical research; (4) NOT a celiac disease treatment.
EVIDENCE-BASED USES: (1) Accidental gluten exposure support; (2) Non-celiac gluten sensitivity adjunct; (3) Travel/dining out safety net.
CRITICAL CAUTIONS: (1) NOT FOR CELIAC DISEASE TREATMENT — celiac disease requires STRICT GLUTEN AVOIDANCE; GluteAX is NOT a substitute for gluten-free diet; do NOT use to enable gluten consumption; (2) FOR ACCIDENTAL EXPOSURE ONLY — Akay's positioning for occasional accidental exposure not routine gluten consumption; (3) NON-CELIAC GLUTEN SENSITIVITY — emerging area; some benefit reported; (4) SYMPTOM MANAGEMENT vs IMMUNE PROTECTION — enzymes may reduce some symptoms but autoimmune response in celiac may still occur; gluten-free diet remains foundation; (5) DOSE — per BIO-CAT specification; (6) GLUTEAX vs DPP-IV ENZYMES — similar mechanism category; specific BIO-CAT formulation; (7) FOR TRUE CELIAC DISEASE — strict gluten-free diet, vigilance about cross-contamination, possibly nutrient deficiency screening; enzymes adjunctive; (8) BRAND VERIFICATION — GluteAX® is BIO-CAT trademark; (9) IMPORTANT MESSAGING — products like GluteAX should clearly communicate they are NOT cures for celiac disease.